Clinical Trials Browser

Phase 2 × Drug Screening Assays, Antitumor × Breast × Clear all

NCT00003253 2013-12-19

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Breast Neoplasms, Male